# Jennifer L. Hsu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jennifer-l-hsu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,156 |
| Field | Immune Cell Function and Interaction |
| h-index | 54 |
| i10-index | 115 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5018650939 |
| ORCID iD | https://orcid.org/0000-0001-9920-0720 |
| Works | 357 |

## Researcher papers

- [Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1](https://scholariq.org/papers/metformin-promotes-antitumor-immunity-via-endoplasmic-reticulum-associated/)
- [Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy](https://scholariq.org/papers/removal-of-n-linked-glycosylation-enhances-pd-l1-detection-and-predicts-anti-pd/)

## Researcher topics

- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.